Polygon Management »

Cytokinetics shares owned by Polygon Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Polygon Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 11M 1.78
2023-09-30 $30M 35M 0.86

More positions owned by Polygon Management

Uipath Cl A (PATH)
Autolus Therapeutics Spon Ads (AUTL)
Lyft Cl A Com (LYFT)
Kolibri Global Energy Com New (KGEI)
Takeda Pharmaceutical Sponsored Ads (TAK)
Sprinklr Cl A (CXM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Bally's Corp (BALY)
Lithium Americas Argentina C Note 1.750% 1/1 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Alteryx Com Cl A
Ncl Corp Note 6.000% 5/1 (Principal)
Tarsus Pharmaceuticals (TARS)
Eagle Bulk Shipping Note 5.000% 8/0 (Principal)
Ati Note 3.500% 6/1 (Principal)

View all positions for Polygon Management

Top funds holding Cytokinetics

Wolverine Asset Management
Weiss Asset Management LP[1
D. E. Shaw & Co
Balyasny Asset Management
Millennium Management
DeepCurrents Investment Group
Graham Capital Management
Point72 Asset Management
Readystate Asset Management
Polygon Management
CNH Partners
Jane Street
Partner Fund Management
Polar Securities
Lord, Abbett & Co

View all funds holding Cytokinetics